Dolby Laboratories (DLB) Stock Analysis
Range Bound setup
Industrials · Specialty Business Services
Wait — supporting gate not met yet. Price is at or below entry $62.78 but weak momentum; below 200-day MA (death cross) still blocks BUY_NOW. Key risk: Leverage penalty (D/E 1.6): -1.0.
Dolby Laboratories licenses audio and video technology (Dolby Atmos, Dolby Vision, codecs) to ~1,000 device manufacturers representing 93% of fiscal 2025 revenue, and sells cinema products to exhibitors. Revenue protected by 28,400+ issued patents enabling entertainment... Read more
Wait — supporting gate not met yet. Price is at or below entry $62.78 but weak momentum; below 200-day MA (death cross) still blocks BUY_NOW. Key risk: Leverage penalty (D/E 1.6): -1.0. Chart setup: RSI 59 mid-range, Bollinger mid-band. Earnings in 0 days. Wait until post-earnings. Score 5.7/10, moderate confidence.
Passes 4/7 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, semi cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA) and earnings proximity 0d<=7d. Suitability: moderate.
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- MEDIUMCustomersmall number of key licensees10-K Item 1A: 'A small number of our licensees or other customers may represent a significant percentage of our Licensing, Products, or Services revenue'
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
1 floor-breaker
Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Wait — supporting gate not met yet. Price is at or below entry $62.78 but weak momentum; below 200-day MA (death cross) still blocks BUY_NOW. Key risk: Leverage penalty (D/E 1.6): -1.0. Chart setup: RSI 59 mid-range, Bollinger mid-band. Earnings in 0 days. Wait until post-earnings. Target $68.85 (+10.0%), stop $60.12 (−4.1%), Setup A.R:R 2.9:1. Score 5.7/10, moderate confidence.
Take-profit target: $68.85 (+12.7% upside). Target $68.85 (+10.0%), stop $60.12 (−4.1%), Setup A.R:R 2.9:1. Stop-loss: $60.12.
Leverage penalty (D/E 1.6): -1.0.
Dolby Laboratories trades at a P/E of 25.6 (forward 13.7). TrendMatrix value score: 6.9/10. Verdict: Buy (Wait for Entry).
11 analysts cover DLB with a consensus score of 4.0/5. Average price target: $81.
What does Dolby Laboratories do?Dolby Laboratories licenses audio and video technology (Dolby Atmos, Dolby Vision, codecs) to ~1,000 device...
Dolby Laboratories licenses audio and video technology (Dolby Atmos, Dolby Vision, codecs) to ~1,000 device manufacturers representing 93% of fiscal 2025 revenue, and sells cinema products to exhibitors. Revenue protected by 28,400+ issued patents enabling entertainment experiences across TVs, PCs, mobile devices, gaming, and streaming.